老人病学
发表于 2025-3-28 18:07:45
Tumor Infiltrating Lymphocytes (TIL): From Bench to Bedside using mouse models beginning in the first half of the twentieth century led to pioneering work carried out by the group led by Steven A. Rosenberg at the Surgery Branch of the National Cancer Institute (NCI) that developed adoptive cellular therapy (ACT) with tumor infiltrating lymphocytes (TIL). N
摘要
发表于 2025-3-28 21:15:19
http://reply.papertrans.cn/39/3821/382002/382002_42.png
Ambiguous
发表于 2025-3-29 01:05:06
http://reply.papertrans.cn/39/3821/382002/382002_43.png
古代
发表于 2025-3-29 03:48:22
http://reply.papertrans.cn/39/3821/382002/382002_44.png
MOAT
发表于 2025-3-29 09:41:02
René Carbonneau,Richard E. Tremblayin patients with hematologic malignancies, leading to the FDA approval of five CAR-T cells for relapsed or refractory B cell malignancies. The components of these CARs (the extracellular antigen-binding domain, hinge and transmembrane region, co-stimulatory domains, and activation domain) were metho
nauseate
发表于 2025-3-29 11:56:26
http://reply.papertrans.cn/39/3821/382002/382002_46.png
Vulvodynia
发表于 2025-3-29 17:14:28
http://reply.papertrans.cn/39/3821/382002/382002_47.png
一条卷发
发表于 2025-3-29 21:17:41
http://reply.papertrans.cn/39/3821/382002/382002_48.png
过时
发表于 2025-3-30 02:50:33
http://reply.papertrans.cn/39/3821/382002/382002_49.png
Mhc-Molecule
发表于 2025-3-30 06:28:12
http://reply.papertrans.cn/39/3821/382002/382002_50.png